Brief: Mauna Kea, On Target Laboratories Show New Approach In Lung Cancer Detection
May 18 (Reuters) - MAUNA KEA TECHNOLOGIES SAS MKEA.PA :
* ON TARGET LABORATORIES AND MAUNA KEA TECHNOLOGIES
DEMONSTRATE
INTRAPROCEDURAL TARGETED DETECTION OF LUNG CANCER WITH A
MOLECULAR IMAGING AGENT
* NEW APPROACH CAN IDENTIFY SMALL VOLUMES OF CANCER IN TYPE
OF
PULMONARY NODULE KNOWN WHICH IS PARTICULARLY CHALLENGING TO
IDENTIFY, DIAGNOSE
Source text for Eikon: ID:nBw4p1h7Wa
Further company coverage: MKEA.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on Mauna Kea Technologies SA
See all newsBrief: Mauna Kea Technologies Confirms Trajectory Toward Profitability By Year-End 2027
Brief: Mauna Kea Technologies Announces Results Of Its Combined General Meeting
French and Benelux stocks-Factors to watch 21 Nov
Brief: Mauna Kea Technologies Receives NMPA Regulatory Approval In China For Its Next-Generation Cellvizio Platform
Europe Research Roundup: Craneware, Croda, Genus